Cargando…
Optimization of Anti-SARS-CoV-2 Neutralizing Antibody Therapies: Roadmap to Improve Clinical Effectiveness and Implementation
One of the major breakthroughs to combat the current Coronavirus Disease 2019 (COVID-19) pandemic has been the development of highly effective vaccines against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). Still, alternatives are needed for individuals who are at high risk of dev...
Autores principales: | van der Straten, Karlijn, van Gils, Marit J., de Taeye, Steven W., de Bree, Godelieve J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8996231/ https://www.ncbi.nlm.nih.gov/pubmed/35419561 http://dx.doi.org/10.3389/fmedt.2022.867982 |
Ejemplares similares
-
HIV-1 escapes from N332-directed antibody neutralization in an elite neutralizer by envelope glycoprotein elongation and introduction of unusual disulfide bonds
por: van den Kerkhof, Tom L. G. M., et al.
Publicado: (2016) -
Discriminating cross-reactivity in polyclonal IgG1 responses against SARS-CoV-2 variants of concern
por: van Rijswijck, Danique M. H., et al.
Publicado: (2022) -
Broad SARS-CoV-2 neutralization by monoclonal and bispecific antibodies derived from a Gamma-infected individual
por: Guerra, Denise, et al.
Publicado: (2023) -
The effect of SARS-CoV-2 vaccination on post-acute sequelae of COVID-19 (PASC): A prospective cohort study
por: Wynberg, Elke, et al.
Publicado: (2022) -
HIV-1 immunogens and strategies to drive antibody responses towards neutralization breadth
por: van Schooten, Jelle, et al.
Publicado: (2018)